Gail Rowan
Gail’s main area of practice and interest includes the treatment of haematological malignancies, minimisation of anti-cancer therapy related adverse effects and education on the safe use of anti-cancer therapies especially oral therapies.
Gail is past chair and a current committee member of the Cancer Pharmacists Group (CPG) of COSA, and a member of the Leadership Committee of the SHPA Oncology & Haematology Specialty Practice Group, and is qualified as a Board Certified Oncology Pharmacist (BCOP) through the Board of Pharmaceutical Specialities in the United States.
Abstracts this author is presenting:
